SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma

Peng,Fenghui; Zhong,Yanping; Liu,Yunfeng; Zhang,Yueming; Xie,Yihong; Lu,Yingxin; Zhang,Xinyin; Li,Danrong

doi:10.3892/ijo.2017.4168

SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma

Authors:
- Fenghui Peng
- Yanping Zhong
- Yunfeng Liu
- Yueming Zhang
- Yihong Xie
- Yingxin Lu
- Xinyin Zhang
- Danrong Li
View Affiliations

Affiliations: Affliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China, Medical Scientific Research Center, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China
Published online on: October 19, 2017 https://doi.org/10.3892/ijo.2017.4168
Pages: 1920-1928

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lymph node metastasis is one of the most valuable determinants for the prognosis of ovarian cancer. However, the molecular mechanisms underlying lymphangiogenesis in ovarian cancer is still poorly understood. Secreted protein acidic and rich in cysteine (SPARC), a Ca2+-binding matricellular glycoprotein that modulates cell adhesion, migration and differentiation, is thought to play a decisive role in tumor metastasis. Vascular endothelial growth factor (VEGF)-C and VEGF-D contributes to tumor-associated lymphatic vessel growth, enhancing the metastatic spread of tumor cells to lymph nodes. The aim of the present study was to investigate the relationship among SPARC, VEGFs and lymph node metastasis in ovarian cancer. We found that SKOV3 cells expressed high-level SPARC, much more than SKOV3-PM4 cells (a subline with high directional lymphatic metastatic potentials established from the metastatic lymph node generated by human ovarian carcinoma cell line SKOV3 in nude mice) did at both mRNA and protein levels. A SPARC-overexpressed SKOV3-PM4 cell line was constructed and it was found that upregulation of SPARC expression suppressed the growth, migration and invasion of SKOV3-PM4 cells as well as markedly reduced the expression of VEGF-D at both mRNA and protein level by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot assay. In 47 of ovarian malignant tissues, the expression of SPARC, VEGF-C and VEGF-D were determined by immunohistochemistry. Lymphatic microvessel density (LVD) and microvessel density (MVD) were evaluated by immunostaining with CD34 and D2-40 antibodies, respectively. We found that SPARC expression was significantly lower in tissues with lymph node metastasis as compared to tissues without lymph node metastasis. SPARC expression was inversely associated with the degree of malignancy and it had a negative correlation with VEGF-C expression, VEGF-D expression, LVD and MVD which were actually higher for advanced tumors than for non-advanced tumors. These results suggest SPARC might function as a tumor suppressor inhibiting angiogenesis and lymphangiogenesis in ovarian cancer by reducing the expression of VEGF-C and VEGF-D.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Lengyel E: Ovarian cancer development and metastasis. Am J Pathol. 177:1053–1064. 2010. View Article : Google Scholar : PubMed/NCBI
3	Ruan HY, Li DR, Li L, Guan X and Zhang W: Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics. Zhonghua Fu Chan Ke Za Zhi. 42:482–486. 2007.In Chinese. PubMed/NCBI
4	Zhang XY, Yin FQ, Liu L, Gao T, Ruan HY, Guan X, Lu YX and Li DR: Effects of HLEC on the secreted proteins of epithelial ovarian cancer cells prone to metastasize to lymph nodes. Cancer Biol Med. 10:221–226. 2013.PubMed/NCBI
5	Sage H, Johnson C and Bornstein P: Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J Biol Chem. 259:3993–4007. 1984.PubMed/NCBI
6	Bornstein P and Sage EH: Matricellular proteins: Extracellular modulators of cell function. Curr Opin Cell Biol. 14:608–616. 2002. View Article : Google Scholar : PubMed/NCBI
7	Hsiao YH, Lien HC, Hwa HL, Kuo WH, Chang KJ and Hsieh FJ: SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. Breast J. 16:305–308. 2010. View Article : Google Scholar : PubMed/NCBI
8	Thomas R, True LD, Bassuk JA, Lange PH and Vessella RL: Differential expression of osteonectin/SPARC during human prostate cancer progression. Clin Cancer Res. 6:1140–1149. 2000.PubMed/NCBI
9	Sato T, Oshima T, Yamamoto N, Yamada T, Hasegawa S, Yukawa N, Numata K, Kunisaki C, Tanaka K, Shiozawa M, et al: Clinical significance of SPARC gene expression in patients with gastric cancer. J Surg Oncol. 108:364–368. 2013. View Article : Google Scholar : PubMed/NCBI
10	Chan SK, Griffith OL, Tai IT and Jones SJ: Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev. 17:543–552. 2008. View Article : Google Scholar : PubMed/NCBI
11	Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P and Cohn SL: SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int J Cancer. 118:310–316. 2006. View Article : Google Scholar
12	Zhang JL, Chen GW, Liu YC, Wang PY, Wang X, Wan YL, Zhu J, Gao HQ, Yin J, Wang W, et al: Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer. PLoS One. 7:e446182012. View Article : Google Scholar : PubMed/NCBI
13	Yunker CK, Schultz C, Lemke N, Golembieski WA, Nelson K, Ojetebbe N, Gutierrez JA, Mikkelsen T and Rempel SA: SPARC suppresses and inversely correlates with VEGF expression and secretion in SPARC-transfected U87MG cells and tumors and in primary xenograft human gliomas. Cancer Res. 66:656. 2006.
14	Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY and Vermeulen PB: First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer. 95:1611–1625. 2006. View Article : Google Scholar : PubMed/NCBI
15	Tai IT and Tang MJ: SPARC in cancer biology: Its role in cancer progression and potential for therapy. Drug Resist Updat. 11:231–246. 2008. View Article : Google Scholar : PubMed/NCBI
16	Kim NI, Kim GE, Lee JS and Park MH: In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression. Virchows Arch. 470:91–98. 2017. View Article : Google Scholar
17	Bull Phelps SL, Carbon J, Miller A, Castro-Rivera E, Arnold S, Brekken RA and Lea JS: Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity. Am J Obstet Gynecol. 200:180 e1–7. 2009. View Article : Google Scholar
18	Socha MJ, Said N, Dai Y, Kwong J, Ramalingam P, Trieu V, Desai N, Mok SC and Motamed K: Aberrant promoter methylation of SPARC in ovarian cancer. Neoplasia. 11:126–135. 2009. View Article : Google Scholar : PubMed/NCBI
19	Chen J, Wang M, Xi B, Xue J, He D, Zhang J and Zhao Y: SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer. PLoS One. 7:e424132012. View Article : Google Scholar : PubMed/NCBI
20	Jendraschak E and Sage EH: Regulation of angiogenesis by SPARC and angiostatin: Implications for tumor cell biology. Semin Cancer Biol. 7:139–146. 1996. View Article : Google Scholar : PubMed/NCBI
21	Nakamura Y, Yasuoka H, Tsujimoto M, Kurozumi K, Nakahara M, Nakao K and Kakudo K: Importance of lymph vessels in gastric cancer: A prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer. J Clin Pathol. 59:77–82. 2006. View Article : Google Scholar : PubMed/NCBI
22	Miller JR, Moon RT, Dev G, Cadigan KM, Nusse R, Hart MJ, Santos RDL, Albert IN and Rubinfeld B: Genes expressed in human tumor endothelium. Science. 289:1197–1202. 2000. View Article : Google Scholar
23	Liang JF, Wang HK, Xiao H, Li N, Cheng CX, Zhao YZ, Ma YB, Gao JZ, Bai RB and Zheng HX: Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. J Exp Clin Cancer Res. 29:71–81. 2010. View Article : Google Scholar : PubMed/NCBI
24	Du LC, Chen XC, Wang D, Wen YJ, Wang CT, Wang XM, Kan B, Wei YQ and Zhao X: VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma. Reprod Biol Endocrinol. 12:14–24. 2014. View Article : Google Scholar : PubMed/NCBI
25	Said N, Socha MJ, Olearczyk JJ, Elmarakby AA, Imig JD and Motamed K: Normalization of the ovarian cancer microenvironment by SPARC. Mol Cancer Res. 5:1015–1030. 2007. View Article : Google Scholar : PubMed/NCBI
26	Majumder M, Tutunea-Fatan E, Xin X, Rodriguez-Torres M, Torres-Garcia J, Wiebe R, Timoshenko AV, Bhattacharjee RN, Chambers AF and Lala PK: Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN. PLoS One. 7:e350942012. View Article : Google Scholar
27	Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K and Detmar M: VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood. 109:1010–1017. 2007. View Article : Google Scholar
28	Kumar B, Chile SA, Ray KB, Reddy GE, Addepalli MK, Kumar AS, Ramana V and Rajagopal V: VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway. Angiogenesis. 14:371–380. 2011. View Article : Google Scholar : PubMed/NCBI
29	Bradshaw AD, Reed MJ, Carbon JG, Pinney E, Brekken RA and Sage EH: Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice. Wound Repair Regen. 9:522–530. 2001. View Article : Google Scholar
30	Yan M, Schneider J, Gear R, Lu F, LaDow K, Warshawsky D and Heffelfinger SC: Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies. Pathobiology. 71:253–260. 2004. View Article : Google Scholar : PubMed/NCBI
31	Yu H, Zhang S, Zhang R and Zhang L: The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma. J Exp Clin Cancer Res. 28:98–103. 2009. View Article : Google Scholar : PubMed/NCBI